Number of the records: 1
Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect
- 1.Janikashvili, N., Gérard, C., Thébault, M., Brázdová, A., Boibessot, C., Cladière, C., Ciudad, M., Greigert, H., Ouandji, S., Ghesquière, T., Samson, M., Audia, S., Saas, P., Bonnotte, B. Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect. OncoImmunology. 2021, 10(1), 1880046. ISSN 2162-4011. Available: doi: 10.1080/2162402X.2021.1880046.
Number of the records: 1